DK1093451T3 - Solid compositions suitable for oral administration containing non-hygroscopic salts of L-carnitine and alkanoyl-L-carnitines - Google Patents
Solid compositions suitable for oral administration containing non-hygroscopic salts of L-carnitine and alkanoyl-L-carnitinesInfo
- Publication number
- DK1093451T3 DK1093451T3 DK99929707T DK99929707T DK1093451T3 DK 1093451 T3 DK1093451 T3 DK 1093451T3 DK 99929707 T DK99929707 T DK 99929707T DK 99929707 T DK99929707 T DK 99929707T DK 1093451 T3 DK1093451 T3 DK 1093451T3
- Authority
- DK
- Denmark
- Prior art keywords
- solid compositions
- carnitines
- carnitine
- oral administration
- alkanoyl
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 3
- 239000008247 solid mixture Substances 0.000 title abstract 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical class C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title abstract 2
- -1 alkanoyl L-carnitines Chemical class 0.000 abstract 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/105—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
- C07C65/11—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Non-hygrocopic salts of L-carnitine and of the lower alkanoyl L-carnitines with pamoic acid are described, which are used to prepare solid compositions suitable for oral administration. Solid compositions containing such salts are also described.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT98RM000445A IT1299544B1 (en) | 1998-07-03 | 1998-07-03 | SOLID COMPOSITIONS SUITABLE FOR ORAL ADMINISTRATION INCLUDING NON-HYGROSCOPIC SALTS OF L-CARNITINE AND L-CARNITINE ALCANOYLS |
| PCT/IT1999/000202 WO2000001662A1 (en) | 1998-07-03 | 1999-07-02 | Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and alkanoyl l-carnitines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1093451T3 true DK1093451T3 (en) | 2004-01-05 |
Family
ID=11406029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99929707T DK1093451T3 (en) | 1998-07-03 | 1999-07-02 | Solid compositions suitable for oral administration containing non-hygroscopic salts of L-carnitine and alkanoyl-L-carnitines |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6465515B2 (en) |
| EP (1) | EP1093451B1 (en) |
| JP (1) | JP2002519403A (en) |
| KR (1) | KR100642729B1 (en) |
| AT (1) | ATE248805T1 (en) |
| AU (1) | AU4647999A (en) |
| CA (1) | CA2335503A1 (en) |
| DE (1) | DE69911021T2 (en) |
| DK (1) | DK1093451T3 (en) |
| ES (1) | ES2205843T3 (en) |
| IL (1) | IL140487A (en) |
| IT (1) | IT1299544B1 (en) |
| PT (1) | PT1093451E (en) |
| WO (1) | WO2000001662A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1317048B1 (en) * | 2000-06-23 | 2003-05-26 | Sigma Tau Ind Farmaceuti | USE OF PAMOIC ACID OR ITS DERIVATIVE, OR ANALOGUE, FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF DISEASES |
| JP2006111550A (en) * | 2004-10-13 | 2006-04-27 | Nisshin Pharma Inc | Carnitine-containing products |
| EP4362697A1 (en) * | 2021-06-07 | 2024-05-08 | Kaesler Nutrition GmbH | Carnitine formulation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE51711B1 (en) * | 1977-11-03 | 1987-03-04 | Sigma Tau Ind Farmaceuti | Carnitine derivatives |
| EP0150688B1 (en) * | 1983-12-28 | 1987-04-22 | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same |
| IT1209564B (en) * | 1984-06-29 | 1989-08-30 | Magis Farmaceutici | DERIVATIVES OF L-CARNITINE OR L-ACYL CARNITINE. |
| IT1188176B (en) * | 1985-07-05 | 1988-01-07 | Bicresearch Spa | SALT OF CARNITINE PARTICULARLY SUITABLE FOR ORAL USE |
| DE3841664A1 (en) * | 1988-12-10 | 1990-10-11 | Fresenius Ag | Non-hygroscopic salt of L-carnitine |
| US5073376A (en) * | 1989-12-22 | 1991-12-17 | Lonza Ltd. | Preparations containing l-carnitine |
-
1998
- 1998-07-03 IT IT98RM000445A patent/IT1299544B1/en active IP Right Grant
-
1999
- 1999-07-02 JP JP2000558067A patent/JP2002519403A/en active Pending
- 1999-07-02 CA CA002335503A patent/CA2335503A1/en not_active Abandoned
- 1999-07-02 IL IL14048799A patent/IL140487A/en not_active IP Right Cessation
- 1999-07-02 AU AU46479/99A patent/AU4647999A/en not_active Abandoned
- 1999-07-02 EP EP99929707A patent/EP1093451B1/en not_active Expired - Lifetime
- 1999-07-02 DE DE69911021T patent/DE69911021T2/en not_active Expired - Fee Related
- 1999-07-02 WO PCT/IT1999/000202 patent/WO2000001662A1/en not_active Ceased
- 1999-07-02 PT PT99929707T patent/PT1093451E/en unknown
- 1999-07-02 DK DK99929707T patent/DK1093451T3/en active
- 1999-07-02 KR KR1020017000060A patent/KR100642729B1/en not_active Expired - Fee Related
- 1999-07-02 AT AT99929707T patent/ATE248805T1/en not_active IP Right Cessation
- 1999-07-02 ES ES99929707T patent/ES2205843T3/en not_active Expired - Lifetime
-
2000
- 2000-12-21 US US09/740,786 patent/US6465515B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL140487A0 (en) | 2002-02-10 |
| ITRM980445A0 (en) | 1998-07-03 |
| US6465515B2 (en) | 2002-10-15 |
| EP1093451A1 (en) | 2001-04-25 |
| CA2335503A1 (en) | 2000-01-13 |
| KR100642729B1 (en) | 2006-11-03 |
| US20010009923A1 (en) | 2001-07-26 |
| ES2205843T3 (en) | 2004-05-01 |
| IT1299544B1 (en) | 2000-03-16 |
| EP1093451B1 (en) | 2003-09-03 |
| DE69911021D1 (en) | 2003-10-09 |
| ITRM980445A1 (en) | 2000-01-03 |
| KR20010071720A (en) | 2001-07-31 |
| WO2000001662A1 (en) | 2000-01-13 |
| AU4647999A (en) | 2000-01-24 |
| ATE248805T1 (en) | 2003-09-15 |
| JP2002519403A (en) | 2002-07-02 |
| HK1035710A1 (en) | 2001-12-07 |
| PT1093451E (en) | 2003-12-31 |
| IL140487A (en) | 2004-07-25 |
| DE69911021T2 (en) | 2004-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20003698L (en) | Oral compositions | |
| NO900533L (en) | CONNECTION FOR LUBRICANTS COMPOSITIONS, LUBRICANTS COMPOSITION CONCENTRATE AND PROCEDURE FOR THE PREPARATION OF THE COMPOSITION. | |
| CY1112139T1 (en) | A PHARMACEUTICAL COMPOSITION INCLUDING CRYSTALL RITONAVIR FORM II AND A PREPARATION THEREOF | |
| AR024138A1 (en) | INHIBITORS OF THE CELL PROLIFERATION | |
| DK1166762T3 (en) | Compositions containing mineral water | |
| DK1185253T3 (en) | Oral preparation for administration of a solid combination of tramadol and diclofenac | |
| ATE173394T1 (en) | ORAL COMPOSITIONS | |
| NO983530D0 (en) | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents | |
| DK1409449T3 (en) | Alpha ketoglutarates of active ingredients and compositions comprising these | |
| DE3688182D1 (en) | ORAL COMPOSITION. | |
| FI853763L (en) | 1,3-DIMETHYL-1H-PURIN-2,6-DIONER, SOM INNEHAOLLER 1H-INDOL-3-YL. | |
| DK0634396T3 (en) | Amino acid derivatives and their use as single phalinase inhibitors | |
| EA199900534A1 (en) | IMIDAZOPIRIDAZINS | |
| DK1093451T3 (en) | Solid compositions suitable for oral administration containing non-hygroscopic salts of L-carnitine and alkanoyl-L-carnitines | |
| DK0937043T3 (en) | Substituted tetrahydropyridine derivatives, processes for their preparation and pharmaceutical compositions containing these derivatives | |
| DK0536197T3 (en) | Pure, crystalline form of rifapentine | |
| BRPI9916820B8 (en) | a composition comprising 9 [2 [[bis [(pivaloyloxy) methyl] phosphono] methoxy] ethyl] adenine, tablet or capsule and method | |
| MXPA03003799A (en) | Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride. | |
| EA200000736A1 (en) | PHARMACEUTICAL COMPOSITIONS | |
| DK209384A (en) | 4-PHENYL-TETRAHYDRO-FURANO-PYRIDINES AND ACID ADDITION SALTS, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS | |
| DK1208078T3 (en) | Non-hygroscopic salts of active ingredients having therapeutic and / or nutritional activities and oral administration compositions containing them | |
| BR9808461A (en) | Method for solid compositions suitable for oral administration comprising non-hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoetasulfonic acid. | |
| TR200100906T2 (en) | Benzamide derivatives as thrombin inhibitors | |
| DK0994703T3 (en) | Composition comprising ketanserin and L-carnitine for the treatment of CRPS | |
| NO960271D0 (en) | Thiocarbamoyl compounds used as microbiocides |